跳至主要内容
临床试验/EUCTR2018-001294-25-IT
EUCTR2018-001294-25-IT进行中(未招募)1 期

Regional Hypo-perfusion as metabolic raiser of ventilator-induced lung injury (VILI): pilot clinica trial - CO2 inhalation in severe ARDS on ECMO

FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO0 个研究点目标入组 10 人开始时间: 2019年3月14日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • •ARDS diagnosis (according to Berlin definition), deep sedation and neuromuscular paralysis, controlled mechanical ventilation and veno-venous ECMO
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range: 1
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range 8
  • •F.1.3 Elderly (>=65 years) yes
  • •F.1.3.1 Number of subjects for this age range 2

排除标准

  • •Age lower than 18 years; hemodynamic instability; active air leakage from the lung; neurologic injury or clinical suspicion of increased intracranial pressure; pregnancy, moribundus status; refusal by the attending physician

研究者

相似试验